Literature DB >> 19943205

Antiangiogenic therapies in breast cancer.

Roberta Sarmiento1, Mario Rosario D'Andrea, Francesca Cacciamani, Francesca Salerno, Giampietro Gasparini.   

Abstract

Angiogenesis is a complex, multistep process that is involved in the progression and prognosis of several types of cancer. In particular, it has been demonstrated that angiogenesis plays a central role in the progression of breast cancer. This review evaluates results from clinical trials in which the efficacy of conventional chemotherapeutic agents was compared with that of novel antiangiogenic compounds for the treatment of breast cancer, and provides a summary of trials that were ongoing at the time of publication in the neoadjuvant and adjuvant settings.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19943205

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN： 1472-4472


  6 in total

1.  Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis.

Authors:  Y X Yin; F Shen; H Pei; Y Ding; Hua Zhao; Min Zhao; Q Chen
Journal:  Tumour Biol       Date:  2012-05-30

Review 2.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

3.  Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity.

Authors:  Danfang Zhang; Eva-Maria E Hedlund; Sharon Lim; Fang Chen; Yin Zhang; Baocun Sun; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-18       Impact factor: 11.205

4.  Tumor angiogenesis: pericytes and maturation are not to be ignored.

Authors:  Elham Fakhrejahani; Masakazu Toi
Journal:  J Oncol       Date:  2011-10-09       Impact factor: 4.375

Review 5.  Characteristics of human Ewing/PNET sarcoma models.

Authors:  Beverly A Teicher; Rebecca G Bagley; Cecile Rouleau; Ariel Kruger; Yi Ren; Leslie Kurtzberg
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

6.  Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.

Authors:  Danfang Zhang; Baocun Sun; Xiulan Zhao; Yuemei Ma; Ru Ji; Qiang Gu; Xueyi Dong; Jing Li; Fang Liu; Xiaohua Jia; Xue Leng; Chong Zhang; Ran Sun; Jiadong Chi
Journal:  Mol Cancer       Date:  2014-09-08       Impact factor: 27.401
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.